HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert S Hogg Selected Research

Highly Active Antiretroviral Therapy (HAART)

4/2015Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysis.
3/2015Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.
3/2015AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.
1/2015HAART slows progression to anal cancer in HIV-infected MSM.
1/2014The effect of history of injection drug use and alcoholism on HIV disease progression.
1/2014Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.
1/2014Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada.
9/2013The Holy Grail: The search for undiagnosed cases is paramount in improving the cascade of care among people living with HIV.
8/2013HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.
7/2012Factors predictive of 30-day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Robert S Hogg Research Topics

Disease

41Acquired Immunodeficiency Syndrome (AIDS)
04/2015 - 07/2002
10Disease Progression
03/2015 - 09/2002
8Hepatitis C
02/2015 - 01/2006
8Infection
02/2015 - 09/2002
8HIV Infections (HIV Infection)
08/2010 - 09/2003
3HIV Seropositivity
01/2009 - 01/2003
2Hypersensitivity (Allergy)
02/2008 - 07/2007
1Neoplasms (Cancer)
01/2015
1Anus Neoplasms (Anal Cancer)
01/2015
1Drug Toxicity (Drug Safety)
01/2015
1Alcoholism (Alcohol Abuse)
01/2014
1Malnutrition
05/2012
1Confusion (Bewilderment)
01/2012
1Tuberculosis (Tuberculoses)
09/2011
1Abscess
11/2005
1Opportunistic Infections (Opportunistic Infection)
03/2004
1Overdose
01/2003
1Seizures (Seizure)
01/2003

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
02/2013 - 01/2009
6Carbon MonoxideIBA
02/2015 - 09/2002
4Cocaine (Cocaine HCl)IBA
11/2005 - 01/2003
3Protease Inhibitors (Protease Inhibitor)IBA
08/2014 - 01/2005
2Viral RNAIBA
01/2015 - 08/2014
2Biological Markers (Surrogate Marker)IBA
06/2014 - 07/2010
2Nevirapine (Viramune)FDA Link
02/2008 - 07/2007
2Street Drugs (Illicit Drugs)IBA
09/2005 - 01/2003
2Heroin (Diamorphine)IBA
01/2003 - 01/2003
1TabletsIBA
01/2015
1EnzymesIBA
06/2014
1Hemoglobins (Hemoglobin)IBA
02/2013
1CreatinineIBA
02/2013
1Alanine Transaminase (SGPT)IBA
02/2013
1Aspartic Acid (Aspartate)FDA Link
02/2013
1MicronutrientsIBA
05/2012
1tranilast (N 5')IBA
01/2012
1Vasodilator Agents (Vasodilators)IBA
01/2007
1Lipoproteins (Lipoprotein)IBA
01/2005
1LipidsIBA
01/2005
1Triglycerides (Triacylglycerol)IBA
01/2005
1lopinavir (Kaletra)FDA Link
08/2004
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2004
1Mitochondrial DNA (mtDNA)IBA
09/2003
1P-GlycoproteinIBA
01/2003
1Methadone (Dolophine)FDA LinkGeneric
01/2003
1Stavudine (Zerit)FDA LinkGeneric
08/2002
1CholesterolIBA
08/2002

Therapy/Procedure

33Highly Active Antiretroviral Therapy (HAART)
04/2015 - 07/2002
6Art Therapy
02/2015 - 07/2003
1Aftercare (After-Treatment)
12/2006
1Complementary Therapies (Alternative Medicine)
11/2006
1Drug Therapy (Chemotherapy)
02/2006